Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Clifford

Showing results (121-130 of 398) with videos related to

Pageof 40
Sort By:
Journal of Wildlife Diseases|April 29, 2015
HISTOPATHOLOGY AND RISK FACTORS ASSOCIATED WITH NEOTROMBICULA MICROTI INFESTATION IN THE ENDANGERED AMARGOSA VOLE (MICROTUS CALIFORNICUS SCIRPENSIS)Caitlin N Ott-Conn, Leslie W Woods, Deana L Clifford, et al.
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Improving antimicrobial use: longitudinal assessment of an antimicrobial team including a clinical pharmacistForest W Arnold, L Clifford McDonald, David Newman, et al.
The Journal of Infectious Diseases|March 5, 2021
The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial ResistanceRyan T Ranallo, L Clifford McDonald, Alison Laufer Halpin, et al.
Biomedical Reports|September 26, 2015
Anti-hyperalgesic effects of AG490, a Janus kinase inhibitor, in a rat model of inflammatory painBopaiah P Cheppudira, Thomas H Garza, Lawrence N Petz, et al.
Infection Control and Hospital Epidemiology|March 11, 2015
Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk scoreYing P Tabak, Richard S Johannes, Xiaowu Sun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureusJean B Patel, Laura A Jevitt, Jeffery Hageman, et al.
Infection Control and Hospital Epidemiology|May 9, 2013
Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching studyYing P Tabak, Marya D Zilberberg, Richard S Johannes, et al.
Emerging Infectious Diseases|May 23, 2024
Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and Healthcare-Associated InfectionsMihnea R Mangalea, Alison Laufer Halpin, Melia Haile, et al.
Infection Control and Hospital Epidemiology|April 20, 2006
Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physiciansForest W Arnold, L Clifford McDonald, R Scott Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2022
Are Vancomycin Non-Susceptible Clostridioides difficile Strains Emerging?Joseph D Lutgring, Susannah L McKay, Amy S Gargis, et al.
Pageof 40

Showing results (121-130 of 398) with videos related to

Sort By:
Pageof 40
Journal of Wildlife Diseases|April 29, 2015
HISTOPATHOLOGY AND RISK FACTORS ASSOCIATED WITH NEOTROMBICULA MICROTI INFESTATION IN THE ENDANGERED AMARGOSA VOLE (MICROTUS CALIFORNICUS SCIRPENSIS)Caitlin N Ott-Conn, Leslie W Woods, Deana L Clifford, et al.
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Improving antimicrobial use: longitudinal assessment of an antimicrobial team including a clinical pharmacistForest W Arnold, L Clifford McDonald, David Newman, et al.
The Journal of Infectious Diseases|March 5, 2021
The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial ResistanceRyan T Ranallo, L Clifford McDonald, Alison Laufer Halpin, et al.
Biomedical Reports|September 26, 2015
Anti-hyperalgesic effects of AG490, a Janus kinase inhibitor, in a rat model of inflammatory painBopaiah P Cheppudira, Thomas H Garza, Lawrence N Petz, et al.
Infection Control and Hospital Epidemiology|March 11, 2015
Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk scoreYing P Tabak, Richard S Johannes, Xiaowu Sun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureusJean B Patel, Laura A Jevitt, Jeffery Hageman, et al.
Infection Control and Hospital Epidemiology|May 9, 2013
Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching studyYing P Tabak, Marya D Zilberberg, Richard S Johannes, et al.
Emerging Infectious Diseases|May 23, 2024
Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and Healthcare-Associated InfectionsMihnea R Mangalea, Alison Laufer Halpin, Melia Haile, et al.
Infection Control and Hospital Epidemiology|April 20, 2006
Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physiciansForest W Arnold, L Clifford McDonald, R Scott Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2022
Are Vancomycin Non-Susceptible Clostridioides difficile Strains Emerging?Joseph D Lutgring, Susannah L McKay, Amy S Gargis, et al.
Pageof 40